Work

Клініко-імунологічна ефективність застосування кверцетину у хворих на бронхіальну астму у поєднанні із вісцеральним ожирінням

Year: 2009
Type: article
Abstract: The article deals with the results of clinical use of 5-lipoxygenase inhibitor quercetin in comparison with standard treatment of bronchial asthma and visceral obesity. Combined therapy with quercetin addition provides a greater clinical effectiveness as a reliable improvement of pulmonary-function testing, decrease of disturbances in cell immunity, reduction of proinflammatory cytokine and leukotriene production, increase of anti-inflammatory interleukin-10. The results allow to recommend quercetin as a drug of pathogenetic management of patients with bronchial asthma associated with visceral obesity.
Language: Ukrainian
Field: Medicine
Open Access status: green
OpenAlex ID: W985604202
FWCI:
Cites: 11
Cited by: 1
Related to: 10